HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric T Choi Selected Research

Caspase 1 (ICE Protease)

11/2021Procaspase-1 patrolled to the nucleus of proatherogenic lipid LPC-activated human aortic endothelial cells induces ROS promoter CYP1B1 and strong inflammation.
1/2021Canonical Secretomes, Innate Immune Caspase-1-, 4/11-Gasdermin D Non-Canonical Secretomes and Exosomes May Contribute to Maintain Treg-Ness for Treg Immunosuppression, Tissue Repair and Modulate Anti-Tumor Immunity via ROS Pathways.
1/2018Uremic toxins are conditional danger- or homeostasis-associated molecular patterns.
10/2017A comprehensive data mining study shows that most nuclear receptors act as newly proposed homeostasis-associated molecular pattern receptors.
1/2016Caspase-1 mediates hyperlipidemia-weakened progenitor cell vessel repair.
4/2015Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric T Choi Research Topics

Disease

14Neoplasms (Cancer)
11/2021 - 02/2013
14Inflammation (Inflammations)
11/2021 - 11/2012
10Cardiovascular Diseases (Cardiovascular Disease)
11/2021 - 02/2013
8Chronic Renal Insufficiency
01/2021 - 06/2009
6Autoimmune Diseases (Autoimmune Disease)
11/2021 - 02/2013
5Metabolic Diseases (Metabolic Disease)
01/2018 - 01/2013
4Hyperlipidemias (Hyperlipidemia)
01/2021 - 04/2015
4Atherosclerosis
04/2015 - 08/2003
4Endoleak
10/2010 - 02/2003
4Aneurysm (Aneurysms)
03/2007 - 05/2004
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2018 - 11/2016
3Hyperplasia
04/2016 - 06/2007
2Cytokine Release Syndrome
11/2021 - 01/2021
2Diabetic Foot
05/2021 - 09/2018
2Wounds and Injuries (Trauma)
01/2021 - 01/2019
2Abdominal Aortic Aneurysm
01/2021 - 05/2004
2Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 11/2012
2Insulin Resistance
01/2020 - 01/2018
2Hyperhomocysteinemia
01/2017 - 11/2016
2Myocardial Infarction
01/2017 - 01/2016
2Ischemia
07/2015 - 02/2015
2Fistula
01/2015 - 03/2010
2Pathologic Constriction (Stenosis)
09/2014 - 07/2004
2Arteriovenous Fistula
09/2014 - 03/2010
2Atherosclerotic Plaque (Atheroma)
06/2007 - 05/2005
2Neointima
06/2007 - 03/2004
1Infections
11/2021
1Peripheral Arterial Disease
05/2021
1Ulcer
05/2021
1Hypertension (High Blood Pressure)
01/2021
1Coronavirus Infections
01/2021
1Viremia
01/2021
1COVID-19
01/2021
1Thromboembolism
01/2021
1Immune System Diseases (Immune Disorders)
01/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020
1Disease Progression
01/2020
1Leukemia
01/2019
1Chronic Disease (Chronic Diseases)
01/2019
1Bacterial Infections (Bacterial Infection)
01/2019
1Chondrosarcoma
01/2019
1Hyperthermia
01/2019
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2019
1Hypoxia (Hypoxemia)
01/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2018
1Thrombosis (Thrombus)
01/2017
1Prostatic Neoplasms (Prostate Cancer)
01/2017
1Lung Neoplasms (Lung Cancer)
01/2017

Drug/Important Bio-Agent (IBA)

8CytokinesIBA
01/2021 - 02/2013
6EnzymesIBA
11/2021 - 07/2015
6Caspase 1 (ICE Protease)IBA
11/2021 - 04/2015
6Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2012
5InflammasomesIBA
01/2021 - 01/2013
5Apolipoproteins E (ApoE)IBA
01/2020 - 05/2005
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2014
3Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2018
3CaspasesIBA
01/2021 - 04/2016
3ApolipoproteinsIBA
12/2014 - 08/2003
2LipidsIBA
11/2021 - 01/2019
2AntioxidantsIBA
01/2021 - 01/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 02/2013
2Histones (Histone)IBA
01/2020 - 02/2016
2ChromatinIBA
01/2019 - 11/2016
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2017
2Oxygen (Dioxygen)IBA
10/2017 - 01/2017
2CD40 Ligand (CD40L)IBA
01/2017 - 11/2016
2LigandsIBA
01/2013 - 11/2012
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2021
1InterferonsIBA
11/2021
1ChemokinesIBA
01/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2021
1Angiotensin IIIBA
01/2021
1CEACAM1 ProteinIBA
01/2021
1oxidized low density lipoproteinIBA
01/2021
1Coronavirus ReceptorsIBA
01/2021
1Pathogen-Associated Molecular Pattern MoleculesIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Uremic ToxinsIBA
01/2020
1Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2019
1Histocompatibility Antigens Class IIIBA
01/2018
1Rosiglitazone (Avandia)FDA Link
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2017
1Immune Checkpoint ProteinsIBA
01/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017
1Interleukin-18 (Interleukin 18)IBA
01/2017
1S-Adenosylmethionine (Ademetionine)IBA
11/2016
1S-AdenosylhomocysteineIBA
11/2016
1HomocysteineIBA
11/2016

Therapy/Procedure

7Therapeutics
11/2021 - 02/2013
4Stents
10/2010 - 07/2004
3Transplantation
11/2021 - 01/2021
3Ligation
02/2015 - 03/2004
3Renal Dialysis (Hemodialysis)
01/2015 - 11/2012
2Surgical Amputation (Amputations)
05/2021 - 09/2018
2Lasers (Laser)
02/2015 - 03/2010
1Endovascular Procedures
05/2021
1Organ Transplantation
01/2021
1Transjugular Intrahepatic Portasystemic Shunt
01/2019
1Limb Salvage
09/2018